Dr. Agarwal's Health Care Share Price | Dr. Agarwal's Health Care Stock Screener
AGARWALEYE
Hospitals
Share Price NSE
₹479.95
▲
0.35 (0.07%)
Share Price BSE
₹480.10
▲
0.80 (0.17%)
As of May 27, 2026, the Dr. Agarwal's Health Care share price (NSE: AGARWALEYE) is ₹479.95 on NSE and ₹480.10 on BSE, up 0.07% from the previous close, with shares trading between ₹475.25 and ₹486.00, and a 52-week range of ₹334.05–₹542.10.
Check AGARWALEYE 52-week high low for the annual price range and momentum.
Use the Dr. Agarwal's Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Dr. Agarwal's Health Care Market Cap
₹15,194.09 Cr.
AGARWALEYE P/E Ratio (TTM)
90.43
Dr. Agarwal's Health Care P/B Ratio
7.52
EPS (TTM)
₹4.21
Dividend Yield
-
Debt to Equity
0.60
AGARWALEYE 52 Week High
₹542.10
Dr. Agarwal's Health Care 52 Week Low
₹334.05
Operating Margin
29.00%
Profit Margin
8.65%
AGARWALEYE Revenue (TTM)
₹578.00
EBITDA
₹175.00
Net Income
₹50.00
Total Assets
₹3,942.00
Total Equity
₹2,026.00
Dr. Agarwal's Health Care Share Price Chart
Screen Dr. Agarwal's Health Care share price with an interactive chart. Analyse AGARWALEYE price trends and volatility across different timeframes.
Dr. Agarwal's Health Care Company Profile - Fundamental Screener
Screen Dr. Agarwal's Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AGARWALEYE shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE943P01029
Dr. Agarwal's Health Care Balance Sheet Screener
Screen AGARWALEYE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 3,942 | 3,672 | 2,753 | 1,825 | 1,026 | 787 | 752 |
| Current Assets | 573 | 794 | 759 | 310 | 228 | 155 | 146 |
| Fixed Assets | 2,378 | 2,523 | 1,746 | 1,293 | 702 | 575 | 551 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,361 | 1,267 | 974 | 865 | 586 | 438 | 339 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 2,026 | 1,927 | 1,380 | 659 | 234 | 199 | 267 |
| Share Capital | 32 | 32 | 9 | 8 | 7 | 7 | 7 |
| Reserves & Surplus | 1,994 | 1,835 | 1,330 | 622 | 206 | 177 | 242 |
Dr. Agarwal's Health Care Income Statement Screener - Profit & Revenue Analysis
Screen Dr. Agarwal's Health Care income statement and profit fundamentals.
Analyze AGARWALEYE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dr. Agarwal's Health Care share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 578 | 476 | 501 | 507 | 540 | 369 | 410 | 429 | 443 | 345 |
| Expenses | 403 | 332 | 360 | 363 | 386 | 241 | 300 | 310 | 316 | 244 |
| EBITDA | 175 | 144 | 141 | 144 | 155 | 128 | 110 | 119 | 128 | 101 |
| Operating Profit % | 29.00% | 28.00% | 26.00% | 27.00% | 27.00% | 31.00% | 26.00% | 26.00% | 27.00% | 27.00% |
| Depreciation | 77 | 60 | 63 | 68 | 69 | 47 | 56 | 57 | 58 | 43 |
| Interest | 22 | 25 | 25 | 23 | 21 | 27 | 27 | 28 | 28 | 22 |
| Profit Before Tax | 77 | 59 | 54 | 54 | 65 | 54 | 27 | 33 | 41 | 36 |
| Tax | 27 | 16 | 16 | 17 | 21 | 13 | 9 | 12 | 13 | 13 |
| Net Profit | 50 | 43 | 38 | 37 | 44 | 41 | 18 | 21 | 28 | 23 |
| EPS | 1.25 | 1.04 | 0.95 | 0.94 | 1.07 | 1.39 | 0.43 | 0.45 | 0.73 | 1.94 |
Dr. Agarwal's Health Care Cash Flow Screener - Liquidity Fundamentals
Screen AGARWALEYE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 360 | 346 | 233 | 164 | 99 | 103 |
| Investing Activities | -750 | -914 | -509 | -155 | -46 | -85 |
| Financing Activities | 382 | 553 | 303 | 35 | -37 | -74 |
| Net Cash Flow | -8 | -15 | 27 | 44 | 17 | -56 |
Dr. Agarwal's Health Care Shareholding Pattern Screener
See Dr. Agarwal's Health Care shareholding pattern with promoter, FII, and DII holdings.
Check Dr. Agarwal's Health Care promoter holding and ownership changes for AGARWALEYE on TickJournal.
| Item | 2026-Mar | 2025-Jan | 2025-Feb | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 32.36% | 37.73% | 32.45% | 32.45% | 32.42% | 32.42% | 32.39% | 37.83% |
| FII Holding | 57.94% | 0.00% | 56.97% | 60.62% | 59.26% | 58.13% | 58.06% | 0.00% |
| DII Holding | 7.83% | 0.00% | 5.10% | 5.21% | 6.44% | 7.92% | 7.78% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 1.68% | 0.00% | 4.79% | 1.61% | 1.74% | 1.41% | 1.62% | 0.00% |
| Other Holding | 0.19% | 62.27% | 0.69% | 0.11% | 0.14% | 0.11% | 0.15% | 62.17% |
| Shareholder Count | 43,538 | 43 | 217,289 | 68,696 | 63,021 | 48,168 | 46,554 | 29 |
Dr. Agarwal's Health Care Share Dividend Screener - Share Yield Analysis
Check Dr. Agarwal's Health Care dividend history with payout and yield data.
View Dr. Agarwal's Health Care dividend details including ex-dates and amounts for AGARWALEYE stock.
Dr. Agarwal's Health Care Stock Index Membership
See which indices include Dr. Agarwal's Health Care stock.
Check AGARWALEYE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSEIPO
NIFTY IPO
Dr. Agarwal's Health Care Market Events Screener - Corporate Actions
Get Dr. Agarwal's Health Care corporate actions including splits, bonuses, and buybacks.
Check Dr. Agarwal's Health Care stock events that may affect AGARWALEYE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 6.16% | ||
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 2.95% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | -1.33% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -5.93% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.07% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -6.56% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 11.55% |
Dr. Agarwal's Health Care Competitors Screener - Peer Comparison
Screen AGARWALEYE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 118,745 | 60.02 | 25,229 | 14.70% | 2,032 | 63.72 |
| Max Healthcare Institute | 96,725 | 69.05 | 8,373 | 16.56% | 1,464 | 42.55 |
| Fortis Healthcare | 72,974 | 73.94 | 9,128 | 16.28% | 1,064 | 59.54 |
| Aster DM Healthcare | 39,253 | 91.78 | 4,643 | 8.32% | 384 | 62.10 |
| Narayana Hrudayalaya | 38,653 | 48.63 | 7,896 | 41.63% | 788 | 56.07 |
| Global Health | 33,029 | 60.09 | 4,410 | 16.94% | 584 | 61.14 |
| Krishna Institute of Medical Sciences | 30,721 | 126.29 | 3,905 | 27.31% | 198 | 61.17 |
| Dr. Agarwal's Health Care | 15,194 | 90.43 | 2,080 | 18.39% | 168 | 65.17 |
| Rainbow Childrens Medicare | 13,867 | 52.98 | 1,703 | 8.69% | 262 | 67.78 |
| Park Medi World | 12,409 | 40.99 | 1,679 | 17.77% | 272 | 77.79 |
Dr. Agarwal's Health Care Company Announcements - News Screener
Screen AGARWALEYE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Updates on Acquisition | - | |
| 2026-05-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-23 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-23 | Consolidated And Standalone Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-23 | Board Meeting Outcome for Consolidated And Standalone Audited Financial Results For The Quarter And Year Ended March 31 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-22 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-15 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-14 | Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-11 | Receipt Of Order Passed By The HonBle NCLT In Relation To The Scheme Of Amalgamation Between Dr. AgarwalS Eye Hospital Limited And Dr. AgarwalS Health Care Limited | - |
| 2026-04-08 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Update On Announcement Under Regulation 30 (LODR) Dated February 03 2026 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |